OncoSec Medical Inc (ONCSQ)

[chickpea598]

That is exactly the best takeaway from the fireside chat today. Some of these PD patients also had tumor regression but stppoed treatment due to new lesions and trial criteria. If you look at each case and photos, these patients have very severe melanoma. Of the 21 total patients treated so far the first 9 have had more rounds of previous therapy and their disease is further along. As data matures I think we will see a greater percentage of responders simply because the first 9 were the worst of the worst. Some of the next 11 patients treated are at an earlier stage of their disease and more likely to have a better response. Rigorous criteria....but Oncosec strategy is to get an approval by way of an accelerated approval...and 20% BORR in this "salvage" population will get it done. That means "predicted" peak revenues of $350 million in melanoma is very likely after an approval....and I smell licensing deal or buyout if they clear the first approval hurdle....that would be validation of immunopulse.